Examining Clinical Biomarkers for Patient Selection & Stratification for Inclusion & Exclusion Criteria

Time: 8:30 am
day: Day 2


  • Discuss the integration of inflammasome biomarker data into clinical decision-making processes
  • Investigate the utility of inflammasome-related biomarkers in stratifying patient populations based on disease severity, progression, and therapeutic responsiveness
  • Explore the potential of predicting therapeutic outcomes in inflammasome-targeted interventions to enable personalized treatment approaches form optimized patient selection criteria in clinical trials